What are the top competitors of Abbott Laboratories in Healthcare sector?

The top competitors of Abbott Laboratories in the Healthcare sector are: Zimmer Biomet Holdings, Inc. (ZBH.SW), Sonova Holding AG (SOON.SW), Medacta Group S.A. (MOVE.SW), Medartis Holding AG (MED.SW).

Which has better valuations & earnings, Abbott Laboratories or its competitors?

Abbott Laboratories has a market cap of 146.8B and a Dividend Yield of 2.29% compared to its competitors.

Which stock is more profitable: Abbott Laboratories or its competitors?

Abbott Laboratories has an EPS of CHF2.95, while ZBH.SW has an EPS of CHF2.79. So, Abbott Laboratories is more profitable compared to ZBH.SW.

What is Abbott Laboratories stock volatility and risk in terms of investment?

Abbott Laboratories has daily volatility of 1.76% as compared to its competitor ZBH.SW which is 0%. Abbott Laboratories is more volatile as compared to competitors and has high risk.

Is Abbott Laboratories stock profitable?

Abbott Laboratories has a Return on Equity (ROE) of 0.13%. So, Abbott Laboratories is more profitable.

What is Abbott Laboratories stock’s 52 weeks high and low?

Abbott Laboratories stock has a 52-week high of (CHF106) and a low of (CHF84.5).

What was the average volume of Abbott Laboratories stock?

The average volume of Abbott Laboratories is (1) in terms of investment.

Abbott Laboratories (ABT.SW) Competitors

Abbott Laboratories (ABT.SW) Stock Competitors & Peer Comparison

See (ABT.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
ABT.SW	CHF 84.50	-3.98%	146.8B	28.64	CHF 2.95	+2.29%
ZBH.SW	CHF 67.50	-4.26%	13.2B	24.19	CHF 2.79	+1.13%
SOON.SW	CHF 179.75	+0.50%	10.7B	20.64	CHF 8.71	+2.45%
MOVE.SW	CHF 153.80	-0.26%	3.1B	34.95	CHF 4.40	+0.45%
MED.SW	CHF 81.60	+1.49%	1B	121.79	CHF 0.67	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ABT.SW vs ZBH.SW Comparison April 2026

ABT.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ABT.SW stands at 146.8B. In comparison, ZBH.SW has a market cap of 13.2B. Regarding current trading prices, ABT.SW is priced at CHF 84.50, while ZBH.SW trades at CHF 67.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ABT.SW currently has a P/E ratio of 28.64, whereas ZBH.SW's P/E ratio is 24.19. In terms of profitability, ABT.SW's ROE is +0.13%, compared to ZBH.SW's ROE of +0.06%. Regarding short-term risk, ABT.SW is more volatile compared to ZBH.SW. This indicates potentially higher risk in terms of short-term price fluctuations for ABT.SW.Check ZBH.SW's competition here

Abbott Laboratories